Page 4 - Journal of Structural Heart Disease Volume 4, Issue 1

Quality - the key to long-term success
Occlutech was founded in Germany in 2003. Since then we have developed into one of the world’s leading suppliers in the structural heart disease segment, with products and projects for congenital defects, stroke prevention and heart failure.
Our products are sold in over 80 countries globally and close to 100.000 implantations have been carried out, setting the highest standards regarding quality, outcome and patient safety. Obviously, quality and our products’ consistent performance are essential for the trust of
the thousands of physicians who use our products every year.
Quality is key to our long-term success and we will never compromise it. Our dedication to innovation helps physicians around the world to perfect performance that bene t thousands of patients every year.
© Occlutech 2018. All rights reserved. Occlutech is a registered trademark. Individual productavailability subject to local regulatory clearance, may not be available in all territories.The information published in this advertisement is provided by Occlutech for information purposes only and shall not be construed as the giving of advice or making of any recommendation and information presented in this advertisement should not be relied upon as the basis for any decision or action. All information is provided in good faith but without warranty of any kind, express or implied and any use of information or material contained in this advertisement is at the users’ sole risk. Occlutech products are not available for distribution or sales in the US. www.occlutech.com P17F06.026.01